ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
Amount Raised
$112 Million
Round Type
Series B
Investors
Description
ProfoundBio announced an oversubscribed $112 million Series B financing, led by Ally Bridge Group, to advance its clinical-stage Antibody-Drug Conjugate (ADC) pipeline. The funding round also included world-class healthcare dedicated and mutual fund institutional investors.
Quick answer
ProfoundBio raised $112 Million in a Series B round, dated February 13, 2024. Investors: Lilly Asia Ventures, Life Sci Venture Partners, Piper Heartland Healthcare Capital, Octagon Capital, Logos Capital, Medicxi, Surveyor Capital and LYFE Capital. ProfoundBio is based in Woodinville, Washington, United States.
- How much did ProfoundBio raise?
- ProfoundBio raised $112 Million in a Series B round on February 13, 2024.
- Who invested in ProfoundBio?
- Lilly Asia Ventures, Life Sci Venture Partners, Piper Heartland Healthcare Capital, Octagon Capital, Logos Capital, Medicxi, Surveyor Capital and LYFE Capital are named as investors in this round.
- What does ProfoundBio do?
- ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
- Where is ProfoundBio based and how big is it?
- ProfoundBio is based in Woodinville, Washington, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as ProfoundBio that raised within 45 days of this round, from Fundz verified event records.
- CESSATION THERAPEUTICS raised $1M (Seed) on March 29, 2024.
- Vaccinex raised $1.8M (Seed) on March 29, 2024.
- Terragia Biofuel raised $6M (Seed) on March 29, 2024.
- Sense4Med raised $551K (Seed) on March 29, 2024.
- Inomagen Therapeutics raised $200K (Pre-Seed) on March 29, 2024.
- ProtoKinetix raised $35K (Seed) on March 29, 2024.
Who to call at ProfoundBio, and when
A new round usually means ProfoundBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ProfoundBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ProfoundBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ProfoundBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ProfoundBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansProfoundBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.